Guggenheim acted as sole book running manager for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFRX:
- InflaRx announces ordinary shares and warrants offering, no amount given
- InflaRx Secures EU Approval for GOHIBIC in Treating COVID-19-Induced ARDS
- InflaRx announces EC grants marketing authorization to Gohibic for ARDS
- InflaRx Begins Phase 2a Trial for Innovative Anti-Inflammatory Drug
- InflaRx announces first patient dosed in 2a study of CSU, HS